MD MEDICAL GROUP ANNOUNCES BOARD OF DIRECTORS CHANGES
9 March 2022 - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE, MOEX: MDMG), a leading Russian private healthcare provider, today announces changes in its Board of Directors.
Simon Rowlands decided to step down as a member of the Company's Board of Directors. The changes came into effect on March 9, 2022.
Notes:
1. This announcement contains inside information.
*** | |
For further information please contact: | |
Investors | Media |
Renata Battalova | EM |
Head of Investor Relations | Tom Blackwell: +7 919 102 90 64 |
Tel.: +7 917 294 28 82 | Sergii Pershyn: + 1 929 855 81 88 |
r.battalova@mcclinics.ru | MDMG@em-comms.com |
About MD Medical Group |
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 47 modern healthcare facilities, including 8 hospitals and 39 out-patient clinics in 25 of the Russian regions. In 2021, MDMG's revenue amounted to RUB 25.2 billion, up 32% y-o-y. The Company's GDRs are traded on London Stock Exchange (LSE: MDMG) and Moscow Exchange (MOEX: MDMG).
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
MD Medical Group Investments plc published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 13:11:08 UTC.